← Back to All Stocks

Jaguar Health, Inc. (JAGX) Analysis

Generated on: 2025-08-20 19:56:06 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 2,115,759 shares

Analysis Values

Current Price
$1.93
Predicted Price
$2.34
Expected Return
15.64%
Confidence Score
0.78
RSI (14)
45.16
MACD
-0.18
Volume
96,999
Float Shares
2,115,759
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

JAGX

Jaguar Health, Inc.
15.64%
Price: $1.93
Confidence: 0.78
News
Low Float
Last updated: 2025-08-20 19:56:06

Technical Analysis

RSI: 45.16
MACD: -0.18
Technical Analysis Graph

Risk Analysis

Volatility
117.77%
Max Drawdown
-94.44%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Jaguar Health to pursue approval of Canalevia in EU for general diarrhea in dogs
TipRanks - 2025-06-26 13:15
Jaguar Health (JAGX) announced that the company plans to pursue approval from the European Medicines Agency’s Committee for Veterinary Medicinal Products for Canalevia in the European Union for treatment of general diarrhea in dogs. Canalevia, under the name Canalevia-CA1, is conditionally approved by the U.S. Food and Drug Administration as a prescription drug for the treatment of chemotherapy-induced diarrhea in dogs. Jaguar plans to submit a dossier to the European Medicines Agency’s Committe

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.